Brain Communications · Nov 17, 2026
SARS-CoV-2 infection, myelin, and cognition in middle-aged and older adults: The CLSA COVID-19 Brain Health Study
By Boa Sorte Silva NC, Stein RG, Gu Y et al.
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the cause of COVID-19, has been hypothesized to contribute to cognitive decline through effects on myelin. We investigated SARS-CoV-2 infection effects on myelin and cognition in middle-aged and older adults. We analyzed cross-sectional MRI and cognitive data from the Canadian Longitudinal Study on Aging COVID-19 Brain Health Study. We quantified cerebral white matter myelin using myelin water imaging. Cognition included modified Rey Auditory Verbal Learning Test, Mental Alternation Test, and verbal fluency via animal fluency. Analysis of covariance were perfomed to determine differences between SARS-CoV-2 cases and controls adjusting for relevant confounding factors. Exploratory moderation analyses assessed the influence of biological sex, APOE ε4 status, and COVID-19-related symptom incidence and severity. We included 352 community-dwelling individuals with infection status determined at time of MRI scanning (SARS-CoV-2 cases, n = 64; controls, n = 288). Participant mean (SD) age was 65.3 (8.4) years, and 50.3% were female. There were no differences between SARS-CoV-2 cases and controls in myelin content or objective measures of cognition. There were no moderating effects of sex or APOE ε4 status. Cases showed greater incidence (P<0.001) and severity (P<0.001) of COVID-19-related symptoms. Moderation analysis of myelin content revealed significant interactions between symptom incidence and severity with diagnosis group after correcting for multiple comparisons (P corrected < 0.05). Post hoc analysis showed that symptom incidence and severity were inversely associated with myelin content in SARS-CoV-2 cases but not in controls across multiple regions-of-interest. SARS-CoV-2 cases and controls did not differ in myelin content or cognition. Among cases, greater self-reported symptom incidence and severity were associated with lower myelin content, an exploratory finding that requires longitudinal confirmation before it can be interpreted as infection-related myelin loss.